169 related articles for article (PubMed ID: 33652124)
1. A potential role of calpains in sulfonylureas (SUs) -mediated death of human pancreatic cancer cells (1.2B4).
Szymczak-Pajor I; Fleszar K; Kasznicki J; Gralewska P; Śliwińska A
Toxicol In Vitro; 2021 Jun; 73():105128. PubMed ID: 33652124
[TBL] [Abstract][Full Text] [Related]
2. Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing K
Zhang R; Zhou X; Shen X; Xie T; Xu C; Zou Z; Dong J; Liao L
Mol Med; 2018 Sep; 24(1):47. PubMed ID: 30180807
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
[TBL] [Abstract][Full Text] [Related]
4. Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.
Woo MG; Xue K; Liu J; McBride H; Tsang BK
J Biol Chem; 2012 Feb; 287(6):3963-75. PubMed ID: 22117079
[TBL] [Abstract][Full Text] [Related]
5. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
[TBL] [Abstract][Full Text] [Related]
6. Evidence for calpains in cancer metastasis.
Chen J; Wu Y; Zhang L; Fang X; Hu X
J Cell Physiol; 2019 Jun; 234(6):8233-8240. PubMed ID: 30370545
[TBL] [Abstract][Full Text] [Related]
7. Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death.
Magnusson NE; Dyrskjøt L; Grimm D; Wehland M; Pietsch J; Rungby J
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):254-61. PubMed ID: 22642398
[TBL] [Abstract][Full Text] [Related]
8. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
Müller G; Satoh Y; Geisen K
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S115-37. PubMed ID: 8529504
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of conventional sulfonylureas and glimepiride.
Geisen K; Végh A; Krause E; Papp JG
Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
[TBL] [Abstract][Full Text] [Related]
10. Redox Regulation of Calpains: Consequences on Vascular Function.
Randriamboavonjy V; Kyselova A; Fleming I
Antioxid Redox Signal; 2019 Mar; 30(7):1011-1026. PubMed ID: 30266074
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3.
Chen Y; Chen L; Zhang H; Huang S; Xiong Y; Xia C
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):147-154. PubMed ID: 29498478
[TBL] [Abstract][Full Text] [Related]
13. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
[TBL] [Abstract][Full Text] [Related]
14. Caspase-independent death of meiotic and postmeiotic cells overexpressing p53: calpain involvement.
Coureuil M; Fouchet P; Prat M; Letallec B; Barroca V; Dos Santos C; Racine C; Allemand I
Cell Death Differ; 2006 Nov; 13(11):1927-37. PubMed ID: 16528385
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status.
Del Bello B; Moretti D; Gamberucci A; Maellaro E
Oncogene; 2007 Apr; 26(19):2717-26. PubMed ID: 17130844
[TBL] [Abstract][Full Text] [Related]
16. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.
Zeller M; Danchin N; Simon D; Vahanian A; Lorgis L; Cottin Y; Berland J; Gueret P; Wyart P; Deturck R; Tabone X; Machecourt J; Leclercq F; Drouet E; Mulak G; Bataille V; Cambou JP; Ferrieres J; Simon T;
J Clin Endocrinol Metab; 2010 Nov; 95(11):4993-5002. PubMed ID: 20702526
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effects of Three Sulfonylureas (Glibenclamide, Glimepiride, and Gliclazide) on Proliferation and Migration of Vascular Smooth Muscle Cells.
Zhang R; Zou Z; Zhou X; Shen X; Fan Z; Xie T; Xu C; Liao L; Dong J
Cell Physiol Biochem; 2019; 52(1):16-26. PubMed ID: 30790502
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced cell death of HepG2 cells involves a necrotic cell death mediated by calpain.
Kim MJ; Oh SJ; Park SH; Kang HJ; Won MH; Kang TC; Hwang IK; Park JB; Kim JI; Kim J; Lee JY
Apoptosis; 2007 Apr; 12(4):707-18. PubMed ID: 17195093
[TBL] [Abstract][Full Text] [Related]
19. Calpains mediate p53 activation and neuronal death evoked by DNA damage.
Sedarous M; Keramaris E; O'Hare M; Melloni E; Slack RS; Elce JS; Greer PA; Park DS
J Biol Chem; 2003 Jul; 278(28):26031-8. PubMed ID: 12721303
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
